Reduction of intraocular pressure is the sole therapeutic target for glaucoma. Intraocular pressure is determined by the dynamics of aqueous humour secretion and outflow, which comprise several pressure-dependent and pressure-independent mechanisms. Accurately quantifying the components of aqueous humour dynamics is essential in understanding the pathology of glaucoma and the development of new treatments. To better characterise aqueous humour dynamics, we propose a method to directly measure pressure-independent aqueous humour flow. Using the iPerfusion system, we directly measure the flow into the eye when the pressure drop across the pressure-dependent pathways is eliminated. Using this approach we address i) the magnitude of pressure-independent flow in ex vivo eyes, ii) whether we can accurately measure an artificially imposed pressure-independent flow, and iii) whether the presence of a pressure-independent flow affects our ability to measure outflow facility. These studies are conducted in mice, which are a common animal model for aqueous humour dynamics. In eyes perfused with a single cannula, the average pressure-independent flow was 1 [-3, 5] nl/min (mean [95% confidence interval]) (N ¼ 6). Paired ex vivo eyes were then cannulated with two needles, connecting the eye to both iPerfusion and a syringe pump, which was used to impose a known pressureindependent flow of 120 nl/min into the experimental eye only. The measured pressure-independent flow was then 121 [117, 125] nl/min (N ¼ 7), indicating that the method could measure pressureindependent flow with high accuracy. Finally, we showed that the artificially imposed pressureindependent flow did not affect our ability to measure facility, provided that the pressure-dependence of facility and the true pressure-independent flow were accounted for. The present study provides a robust method for measurement of pressure-independent flow, and demonstrates the importance of accurately quantifying this parameter when investigating pressure-dependent flow or outflow facility.
Introduction
Glaucoma is a world leading cause of irreversible blindness (Resnikoff et al., 2004) and elevated intraocular pressure (IOP) is the major risk factor. IOP reduction is the sole clinical objective to prevent further glaucomatous vision loss, regardless of whether IOP is elevated (Van Veldhuisen et al., 2000) . Understanding the physiology of IOP regulation, and its dysregulation in glaucoma, is therefore central to developing and evaluating new IOP-lowering therapies.
IOP is determined by a mass balance between aqueous humour secretion into the eye (Q in ), and aqueous humour outflow, via pressure-independent mechanisms (Q u ) and pressure-dependent mechanisms (characterised by the outflow facility C). A mass balance of the flows entering and exiting the eye yields a form of what is known as Goldmann's equation:
which includes an additional term representing inflow from a perfusion system (Q). P and P e represent IOP and episcleral vessel pressure respectively. Most treatments for glaucoma aim to reduce Q in or increase Q u , with a number of new treatments targeting C (Stamer and Acott, 2012) . IOP elevation in glaucoma is attributed to reduced values of C (Grant, 1951) . Studies of aqueous humour dynamics (AHD) therefore aim to measure the various parameters of Eq.
(1) so as to elucidate the factors controlling IOP.
Mice are common models to study AHD (Aihara et al., 2003; Boussommier-Calleja et al., 2012; Crowston et al., 2004; Lei et al., 2011; Li et al., 2016; Millar et al., 2011 Millar et al., , 2015 Toris et al., 2016; Zhang et al., 2002 Zhang et al., , 2009 . However, some studies report that as much as 60e80% of outflow is pressure-independent in young mice (Aihara et al., 2003; Crowston et al., 2004; Lei et al., 2011) , although the fraction of pressure-independent outflow may decrease with age (Millar et al., 2015) . This contrasts with humans, where the majority of outflow is pressure-dependent (Bill and Phillips, 1971; Toris et al., 1995; Townsend and Brubaker, 1980) , although reported values of the exact proportion vary over a large range, as reviewed by Johnson et al. (2017) . If pressure-independent outflow truly dominates in mice, then the validity of mouse models for AHD becomes questionable. Pressure-independent outflow (Q u ) in post-mortem mice has generally been estimated indirectly by linear extrapolation to estimate the flow rate when P ¼ P e , under conditions where Q in is eliminated (Lei et al., 2011; Millar et al., 2011) . In living mice, Q u has been estimated indirectly by solving Goldmann's equation after measuring C, P e , Q in and spontaneous IOP (Aihara et al., 2003) . Alternatively, the quantity of unconventional (i.e. non-trabecular) outflow has been estimated in living mice based on accumulation of tracer in the uveoscleral tissues (Millar et al., 2011) . As unconventional outflow is typically assumed to exhibit pressureinsensitivity, it is often equated with Q u , although this assumption is questionable (Johnson et al., 2017) .
Here, we present a method to directly measure the net pressureindependent flow, Q 0 , defined as the difference between pressureindependent inflow and outflow according to
To measure Q 0 , we cannulate the anterior chamber with a needle and interface the eye with the iPerfusion system ) that allows direct measurement of Q for a prescribed value of P. By setting P ¼ P e , the pressure-dependent component of outflow is eliminated (see Eq. (1)), enabling a direct measurement of Q 0 . Note that P e ¼ 0 in an enucleated eye.
This report addresses the following questions:
1. What is the magnitude of pressure-independent flow, Q 0 , in enucleated mouse eyes? 2. If pressure-independent flow were present (Q 0 s 0), as in vivo, could it be measured accurately using iPerfusion? 3. Does non-zero pressure-independent flow affect the measurement of outflow facility?
Material and methods

Experimental design
To answer Question 1, we cannulated enucleated mouse eyes with a single cannula connected to iPerfusion, as shown in Fig. 1 . Following a standard perfusion protocol to ensure that the ocular response was normal, the applied pressure was set to zero and the flow rate Q into the eye was measured as P approached zero. To answer Question 2, we cannulated enucleated mouse eyes with two cannulae, providing connections to both iPerfusion and a syringe pump (see Fig. 1 ). The syringe pump was used to impose a known pressure-independent flow directly into one eye. We then asked whether iPerfusion was able to resolve this additional flow rate by direct measurement of Q as P approached zero. To answer Question 3, we compared outflow facility measurements between contralateral eyes, with one eye receiving the imposed pressure-independent flow. As outflow facility is tightly correlated between contralateral enucleated eyes of an individual mouse , a systematic offset in the facility between paired eyes would indicate that the magnitude of pressure-independent flow affects the measurement of facility.
Detailed methods
Animal husbandry
Eyes were obtained from male C57BL/6 mice (Charles River UK, Ltd) aged 9e16 weeks. All mice were housed in clear cages at 21 C with a 12-h light-dark cycle (lights on at 7 a.m.). Food and water were supplied ad libitum. Mice were euthanised by cervical dislocation and eyes were enucleated and stored in PBS at room temperature for no more than 1 h prior to cannulation. The time between death and completion of the perfusion did not exceed 5.5 h. All experiments were performed in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. Experiments were conducted under the authority of a UK Home Office Project Licence.
Ocular perfusion setup
Enucleated eyes were fixed to a platform with a small amount of cyanoacrylate glue (Loctite Precision Super Glue, Henkel, UK) and fully submerged in a bath of PBS maintained at 35.0 ± 0.5 C for the duration of the experiment. Glass needles mounted on micromanipulators were used to cannulate the anterior chamber of the eye under a stereomicroscope. The needles were made by pulling borosilicate glass pipettes (B100-50, Sutter Instrument, USA) in a laser puller (P2000, Sutter Instrument) and were bevelled in a pipette beveller (SYS-48000, WPI, USA) to a 45 taper and a 100 mm outer diameter at the tip. The perfusate used in both cannulae was Dulbecco's PBS with 5.5 mM glucose passed through a sterile 0.22 mm filter prior to use. The flow rate from the iPerfusion system into the eye, Q, at pressure P was measured as described previously (Chandrawati et al., 2017; Li et al., 2016; O'Callaghan et al., 2017; Reina-Torres et al., 2017; Sherwood et al., 2016; Tam et al., 2017; Wang et al., 2017) . As shown in Fig. 1 , iPerfusion comprises an actuated pressure reservoir used to control P a and a thermal flow sensor (SLG64, Sensirion, Switzerland) to measure Q. The pressure within the eye relative to the water bath (P) is measured using a differential pressure sensor (PX409, Omegadyne, USA). In the double cannula experiments, the second needle was connected to a 50 ml glass syringe (Gastight, Hamilton, USA), mounted on a syringe pump (PHD Ultra, Harvard Apparatus, USA). Supplementary Information provides an evaluation of the pump performance measured using the flow sensor.
The thermal flow sensor measures Q through a 75 mm glass capillary, which has a hydrodynamic resistance (R q ) in the range 8e10 mmHg/(ml/min) (measured prior to each perfusion). The pressure in the eye (P) thus differs from the applied reservoir pressure (P a ) according to:
Eq. (3) can be used to set the value of P a in order to achieve a desired P.
The hydrodynamic resistance of the needles, measured prior to each perfusion, was always <0.2 mmHg/(ml/min). Even at a high flow rate of 200 nl/min, this would result in a pressure drop of <0.04 mmHg, which is within the uncertainty of the pressure sensor. The pressure drop across the needle was therefore neglected.
Single cannula experiments
Single eyes from individual mice (N ¼ 6) were cannulated with a single needle and underwent a 9-step pressure perfusion following previous methods . Briefly, following acclimatisation at 8 mmHg for 30 min, the eye was perfused at 9 pressure steps between 4.5 and 21 mmHg. We then measured the flow rate as the pressure approached zero, termed Q (P/0). The approach to zero pressure is asymptotic because the compliance of the eye, as described by Friedenwald's model (Friedenwald, 1937) , is given by 1/KP, where K is the ocular rigidity. Hence the compliance tends towards very high values at low pressures, and larger compliances increase the time to reach steady state. To reduce the time to reach steady state, P was set to 2 mmHg with the flow sensor bypassed (thereby setting R q ¼ 0 in Eq. (3)), instantaneously setting the pressure in the eye to P a . The flow bypass was then closed, and the applied pressure was set to 0 mmHg. Steady state was defined as when the rate of change of P, calculated by linear regression over a 5 min window, was less than 0.01 mmHg/min continuously for 1 min. The mean and standard deviation of Q and P for the pressure step were calculated from the final 4 min of data.
Double cannula experiments
In these experiments, an artificial pressure-independent flow was imposed through the second cannula using the syringe pump (Fig. 1) . The imposed flow rate into the eye was defined to be Q p ¼ 120 nl/min, chosen to approximate the difference between aqueous humour secretion (~150 nl/min), averaged from previous studies (Aihara et al., 2003; Millar et al., 2015 Millar et al., , 2011 Toris et al., 2016) and pressure-independent outflow (~30 nl/min), chosen from the reported range of 0e120 nl/min (Boussommier-Calleja et al., 2012 Boussommier-Calleja and Overby, 2013; Chang et al., 2015; Kumar et al., 2013; Lei et al., 2011; Li et al., 2014; Overby et al., 2014a Overby et al., , 2014b Rogers et al., 2013) .
Paired eyes (N ¼ 7 pairs) were perfused simultaneously on duplicate iPerfusion systems, where contralateral eyes received an imposed flow rate of 0 or 120 nl/min. The perfusion protocol consisted of three phases: I) acclimatisation, II) direct measurement of Q (P/0), and III) characterisation of the flow-pressure relationship to measure C. Fig. 2 shows a sample tracing from a pair of eyes.
2.2.4.1. Phase I: acclimatisation. During phase I the reservoir pressure was set to P a ¼ 9.5 mmHg for 30 min to allow the eye to acclimatise to the perfusion system. 2.2.4.2. Phase II: direct measurement of pressure-independent flow. Phase II is indicated by the blue shaded regions in Fig. 2 . For the control case, where Q p ¼ 0 nl/min, P a was set to 0 mmHg (Fig. 2a) . For the experimental case where Q p ¼ 120 nl/min, P a was set to -R q Q p (see Eq. (3), note that Q ¼ ÀQ p ), using the value of R q measured prior to the perfusion. A period of 60 min was allowed, and the final pressure and Q (P/0) were calculated as the average pressure and flow rate over the final 4 min.
2.2.4.3. Phase III: measuring outflow facility. The flow-pressure relationship was then evaluated over 5 additional pressure steps, equally spaced in the range P a ¼ 3e15 mmHg. Steady state at each step was determined once the rate of change of Q/P, calculated by linear regression over a 5 min window, was continuously less than 0.1 nl/min/mmHg/min for 1 min. The mean and standard deviation of the final 4 min were then extracted and defined as the steady state flow rate and pressure for each step (see green regions in Fig. 2 and data points in Fig. 3) . In order to estimate the outflow facility, we fit a power law model based on our previous study , but with Q 0 added as a free parameter to allow for pressure-independent flow:
where C r is the 'reference facility' at a 'reference pressure' of P r ¼ 8 mmHg, defined based on the physiological pressure drop between the anterior chamber and episcleral vessels. The exponent b characterises the nonlinearity of the flow-pressure relationship.
Eq. (4) was fit to the data using weighted non-linear regression, with weights defined as the reciprocal variance of the flow rate over the 4-min window for each step. Sample flow-pressure plots with best fits and confidence intervals are given in Fig. 3 . Fig. 1 . Schematic of the experimental setup. The iPerfusion system comprises an actuated reservoir to control the applied pressure, a thermal flow sensor to measure the flow rate from the reservoir, and a differential pressure sensor to measure the pressure in the eye with respect to the bath. For the single cannula experiments, the eye was cannulated with one glass needle connected to iPerfusion. For the double cannula experiments, the eye was cannulated with two glass needles, connecting it to both the iPerfusion system and a syringe pump, used to impose a known pressure-independent flow.
Statistics
Statistics for normally distributed data, such as pressure or flow rate, are reported in the form
where, Q is the mean or best fit parameter, ME Q ;95 is the 95% margin of error (the half-width of the 95% confidence interval (CI)) and s Q is the sample standard deviation.
Facility, C, is better represented by a lognormal distribution . Hence the fold change in facility between paired eyes is also lognormally distributed. To account for the multiplicative nature of the lognormal distribution, statistical values of facility, or fold changes in facility, are given in the form
where C * is the geometric mean, with 95% margin of error ME C * ;95
and geometric sample standard deviation s Ã c , as described in our previous study . All statistical analyses on facility were carried out on the log-transformed reference facility, Y r ¼ log (C r ), yielding a normally distributed parameter, Y r , suitable for the t-test.
Results
3.1.
What is the magnitude of pressure-independent flow in enucleated mouse eyes?
We first measured pressure-independent flow at zero pressure in enucleated mouse eyes. Fig. 4a and b show how the pressure and flow rate asymptotically approached zero after setting P a ¼ 0 in the single cannula experiments. Fig. 4c shows the steady state flow and pressure values, with each point representing the mean for a given eye and ellipses indicating two standard deviations. The grey bands indicate the measurement uncertainty of the flow and pressure sensors (see Supplemental Information 1 in Sherwood et al. (2016) ). For these six eyes, the average Q (P/0) was 1 ± 4 (7) nl/ min (see Eq. (5)), which was not significantly different from zero (p ¼ 0.44). The average steady state pressure was approximately zero, 0.04 ± 0.04 (0.07) mmHg, within the accuracy of the pressure sensor. This confirms that there is zero pressure-independent flow in enucleated mouse eyes.
3.2. Can iPerfusion measure pressure-independent flow when it is present? Fig. 5a and b show the values of Q (P/0) measured during Phase II of the double cannula experiments. For the experimental eyes (Fig. 5a ), in which there was a pressure-independent flow into the eye of Q p ¼ 120 nl/min, the mean Q (P/0) was À121 ± 4 (8) nl/ min with a mean P of 0.11 ± 0.07 (0.14) mmHg. Q (P/0) was insignificantly different from -Q p (p ¼ 0.58, N¼7). Note that the negative value of the measured flow rate indicates net flow out of the eye, as expected. For the control eyes (Fig. 5b) , where Q p ¼ 0 nl/ min, the mean Q (P/0) was À10 ± 2 (5) nl/min. The difference between -Q p and Q (P/0) was small but detectible (p < 10 À3 , N ¼ 7), and attributable to the control eyes not having fully reached steady state, as the final mean pressure (0.19 ± 0.02 (0.04) mmHg) had not quite reached zero (p < 10 À3 ). Note that for all control eyes, Q (P/0) was negative and therefore cannot be interpreted as pressure independent outflow, which would yield a positive Q.
Does pressure-independent flow affect facility measured by iPerfusion?
Finally, we consider whether the presence of pressureindependent flow, should it exist as in vivo, affects measurements of outflow facility. Fig. 6 compares the reference facility C r , measured in the contralateral control and experimental eyes, where the ellipses represent the 95% confidence bounds on C r . If an ellipse overlaps the unity line, the difference in facility between the control and experimental eyes of that mouse is not significantly different from zero (equivalent to a fold difference of unity). Analysing all the pairs yields an average fold difference of 0.98 Â / 1.27
(1.67) (see Eq. (6)), which is not significantly different from unity (p ¼ 0.82, N ¼ 7 pairs). The average facility for all 14 eyes was 6.25 Â / 1.14 (1.55) nl/min/mmHg.
Discussion
In the present study, we report the first direct measurements of pressure-independent aqueous humour flow. By equalising the pressure between the eye and the bath, flow across the pressuredependent pathways was eliminated. This left only pressureindependent flow, Q 0 , which represents the difference between inflow and pressure-independent outflow. Using iPerfusion, we demonstrated that Q 0 ¼ 0 in enucleated mouse eyes. Further, when a known Q 0 was imposed, we could accurately measure it. 
The absence of pressure-independent flow ex vivo
For the ex vivo eyes in the present study, aqueous humour secretion would be expected to rapidly approach zero, due to cessation of blood flow. Hence, ex vivo measurements of Q 0 would reflect Q u , the pressure-independent outflow. Our direct measurements gave an average Q 0 of 1 ± 4 (7) nl/min (N ¼ 6). From this, we conclude that the magnitude of the pressure-independent outflow in enucleated mouse eyes is insignificantly different from zero, and if present has a magnitude of less than~5 nl/min. This result is in contrast with prior estimates of pressure-independent outflow in C57BL/6 mice of similar ages, as estimated by extrapolation in enucleated eyes which vary between 0 and 120 nl/ min (Boussommier-Calleja et al., 2015 Boussommier-Calleja and Overby, 2013; Chang et al., 2015; Kumar et al., 2013; Lei et al., 2011; Li et al., 2014; Overby et al., 2014a Overby et al., , 2014b Rogers et al., 2013) . This indicates that linear extrapolation is not an appropriate method for predicting pressure-independent flow in mouse eyes. Although there is no pressure-independent flow in enucleated eyes, there are reports suggesting that pressure-independent flow may exist in eyes perfused in situ following death (Millar et al., 2015 (Millar et al., , 2011 . Additionally, insufficient hydration of the corneoscleral shell during a perfusion can result in an evaporative loss that generates an artefactual pressure-independent outflow (Boussommier-Calleja et al., 2015) .
What about uveoscleral outflow?
The absence of pressure-independent flow does not imply that there is no uveoscleral outflow. In contrast to the functional description of 'pressure-independent flow' used in this study, uveoscleral outflow is an anatomical definition. The uveoscleral outflow pathway comprises flow through gaps in the ciliary muscle, into the supraciliary and suprachoroidal spaces, and thence across the sclera into the extraocular space. Flow through each of these tissues is driven by a pressure gradient, and is hence by definition, pressure-dependent. However, the hydrodynamic resistances of these tissues may vary with pressure.
As flow through the uveoscleral tissues is pressure-dependent, in the absence of a pressure gradient, we would not expect any uveoscleral outflow. At higher pressures, uveoscleral outflow may well occur ex vivo, but it is not possible to distinguish anatomical flow routes (i.e. uveoscleral from trabecular outflow) from perfusion measurements alone.
The value of C measured by perfusion combines the influence of trabecular and uveoscleral outflow facilities, along with any other pressure-dependent flow mechanisms, (including pseudofacility: the pressure-dependent decrease in aqueous humour secretion (Becker and Neufeld, 2002; Kaufman, 2003) ). In vivo, the pressure gradient driving uveoscleral outflow is determined by the intraocular and extraocular pressures, P e P 0 , in contrast to that for trabecular outflow, which is determined by the difference between the intraocular and episcleral vessel pressures, P -P e . Including these terms in Equation (1) yields a form of the modified Goldmann's equation:
where C tr and C u are the trabecular and uveoscleral outflow facilities, respectively, C ps is the pseudofacility, P cc is the ciliary processes capillary pressure and Q u represents any pressureindependent outflow that may be present in vivo, such as that due to uveovortex outflow. For enucleated eyes, there is no aqueous humour production (Q in ¼ 0, C ps ¼ 0), zero pressure-independent outflow (Q u ¼ 0), and extraocular and episcleral vessel pressures are equal to the external reference pressure. Equation (7) thus reduces to:
How does Q 0 affect our interpretation of flow-pressure data?
Pressure-independent outflow has typically been interpreted as the intercept from a linear fit to the flow-pressure data. This ostensibly represents the outflow rate when the pressure drop across all pressure-dependent pathways is eliminated. What has not generally been recognised is that this interpretation has a considerable impact on the assessment of outflow facility. To demonstrate this Fig. 7aec shows different fits to a representative flow-pressure data set, artificially generated based on the average values from iPerfusion measurements of 66 C57BL/6 mice (C r ¼ 5.5 nl/min/mmHg, b ¼ 0.66) . A normally distributed random noise was applied to the flow rates with a standard deviation of 3 nl/min, consistent with previous iPerfusion data (see Supplementary Information 1 in Sherwood et al. (2016) ). Fig. 7a shows the common linear fit (with a finite Q 0 as a free parameter). For this representative case, the fit yields Q 0 ¼ À50 [-60,-32] nl/min (mean [95% CI]), and C r ¼ 12.0 [10.5, 13.6] nl/min/ mmHg. However, as we have demonstrated that Q 0 ¼ 0, this fit is clearly not appropriate, as the estimated value of Q 0 is significantly different from zero. If one enforces Q 0 ¼ 0, but still imposes a linear fit (thereby implicitly defining a constant facility, see Fig. 7b ), the model is clearly not appropriate as it does not capture the form of the data. Hence, it must be concluded that the facility itself is a function of pressure for these measurements. A power law model of the form of Eq. (4), but with Q 0 ¼ 0, can characterise the pressure-dependence of the outflow facility (Fig. 7c) . The reference facility predicted by the power law model is 5. 3 [4.8, 5.7] nl/min/mmHg.
In order to demonstrate how this impacts estimates of facility over a large sample, we re-evaluated data from 66 C57BL/6 mouse eyes described in a previous study . Fig. 7d shows a 'Cello Plot', statistically summarising the proportional difference between the facility estimated using linear (with Q 0 as a free parameter) and power law models. As we have shown that Q 0 ¼ 0 and the facility varies as a function of pressure, using the linear model that does not account for these effects introduces an error in the estimation of outflow facility. The average error was 100% [88, 114%] (mean [95% CI], indicated by the central white line and dark band respectively). The two standard deviation range covers 20e234%, meaning that for a given eye, the error introduced by incorrect use of the common linear model would result in a large but relatively unpredictable error in the estimate of facility. Although the cause of the non-linearity in the present data may be artefactual and the conditions will differ between post mortem and in vivo perfusions, some degree of non-linearity is expected in all data as a linear relationship is a special case.
How does pressure-independent flow affect facility measurements?
Using the power law model with Q 0 as a free parameter (Eq. (4)), we compared the facility between contralateral eyes, with only one eye receiving an imposed Q 0 . The average fold difference between contralateral eyes was 0.98 Â / 1.27 (1.67), which compares well with 1.08 Â / 1.17 (1.57), reported in our previous study for 10 pairs of eyes with a single cannula, following the stepping protocol used for the single cannula experiments. The . two geometric standard deviation levels for the two data sets (1.67 vs 1.57) are similar, indicating that the presence of the pressureindependent flow has negligible impact on our ability to resolve facility, provided that the pressure-dependent changes in facility are accounted for, as with Eq. (4).
Towards in vivo measurements
For in vivo perfusion measurements, the episcleral vessel pressure would be non-zero, and therefore P e would need to be measured to assess Q 0 . Using the technique proposed in the present study, P could be set to P e and Q 0 could be directly measured.
Measurement of P e could be carried out using the method of lowering the intraocular pressure until red blood cells can be observed in Schlemm's canal (Aihara et al., 2003; Millar et al., 2011) . Due to the uncertainty in measuring P e , the acquired Q 0 measurements in vivo would be less accurate than in ex vivo measurements. Considering Eqs. (1) and (2), any inaccuracy in the estimated P e would alter the measured value of Q 0 by a factor of C(P-P e ). Assuming C ¼ 5.5 nl/min/mmHg, if we could identify P e to within ±2 mmHg, this would correspond to an uncertainty of approximately ±10 nl/min in the direct measurement of Q 0 (approximately a 2SD range), indicating that the approach should be robust.
For in vivo measurements, the >60 min required to measure Q (P/0) would be significantly shortened, as at P ¼ P e , the ocular compliance would be reduced several fold compared to P ¼ 0.
Furthermore, newly available flow sensors with 150 mm inner capillaries (Sensirion SLG150) have an R q that is sixteen-fold lower than present sensors with a 75 mm capillary. Hence, we would expect to be able to measure Q 0 within 5 min in vivo, having first determined P e .
Limitations
A single value of pressure-independent flow was investigated, at a magnitude chosen based on various reports of mouse eyes from multiple strains and ages. However, the two standard deviation range from our data suggests that we could have measured any value of Q 0 within approximately 7 nl/min for a given eye. Further experiments requiring more animals were therefore not justified.
This study included only enucleated eyes, and thus neglects the complexity of in vivo AHD. We chose this approach because enucleated eyes provide a platform for validating our method to measure Q 0 that would not be possible in vivo. First, using enucleated eyes reduces the number of unknown parameters in Eq. (1) from three in vivo (C, Q 0 , P e ), to one ex vivo (C), as we have shown that Q 0 ¼ 0 in enucleated eyes under normal perfusion conditions. Thus, ex vivo measurements of C have lower uncertainty than in vivo measurements. Second, enucleated eyes allow us to impose a constant, known value of Q 0 and demonstrate that our method reproduces this value. In vivo, any potential changes in Q in , Q u or P e , as may be caused by anaesthesia for instance, would confound any attempt at validation. Third, enucleated eyes allow tighter control of temperature and hydration, which have been shown to affect measured values of C and Q 0 (Boussommier-Calleja et al., 2015) . Future studies will extend this work to in vivo eyes.
Conclusions
Hitherto, estimates of pressure-independent flow have been made indirectly, by extrapolating a (typically linear) fit to flowpressure data. In this study, we described and tested an approach to directly measure pressure-independent flow in mouse eyes. Using this technique, we showed that in properly hydrated ex vivo mouse eyes, there is no pressure-independent flow, in contrast to previous studies using the extrapolation approach. We then imposed a pressure-independent flow using a syringe pump and demonstrated that we could accurately measure the imposed flow rate. We further demonstrated that the presence of pressureindependent flow did not influence measurements of facility, as long as the pressure-dependence of outflow facility was considered when analysing the data. The technique validated in this study will be applicable to in vivo analyses, enabling the first direct pressureindependent flow measurements in vivo.
